Enjoy complimentary customisation on priority with our Enterprise License!
The assisted reproductive technology (ART ) market size is valued to increase by USD 6.3 billion, at a CAGR of 4.36% from 2023 to 2028. Increase in rate of infertility and obesity-related cases will drive the assisted reproductive technology (ART ) market.
Get Key Insights on Market Forecast (PDF) Request Free Sample
The assisted reproductive technology (ART ) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The fertility clinics segment is estimated to witness significant growth during the forecast period.
Fertility clinics dominated the global assisted reproductive technology (ART) market owing to a worldwide increase in the number of fertility centers to meet the unmet and growing demand of infertility patients. This rise has subsequently increased the consumption of ART solutions, including IVF procedures, artificial insemination, gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). A key factor influencing the inflow of infertility patients is the high improvement in the pregnancy success rates, particularly as clinics optimize ovarian stimulation protocols, embryo transfer techniques, and preimplantation genetic testing (PGT).
Generally, in a fertility clinic, success rates are measured by the number of treatments carried out and the corresponding clinical pregnancy rate or live birth rate. The implantation rate, embryo morphology, and endometrial receptivity are all critical determinants of treatment efficacy and eventual success outcome. As a result, fertility clinics with higher outcomes in terms of reduced miscarriage rate, minimized multiple gestation risk, and lower ectopic pregnancy risk gain popularity not only in domestic but also in international fertility tourism markets.
The Fertility clinics segment was valued at USD 13.88 billion in 2018 and showed a gradual increase during the forecast period.
Another major driver of ART demand is the enhancement of fertility clinic infrastructure to attract medical tourism. This includes advanced capabilities for sperm cryopreservation, egg retrieval, intracytoplasmic sperm injection (ICSI), assisted hatching, blastocyst culture, oocyte selection, and embryo biopsy. Medical tourism growth, however, remains volatile and subject to external conditions such as exchange rates and travel restrictions. Organizations such as ESHRE, ASRM, and ICMART are actively working to harmonize fertility tourism practices and reduce exploitation risks.
Clinical and patient-related factors also play a significant role. Conditions such as uterine fibroids, endometriosis, and variations in uterine lining thickness or hormone levels monitoring can impact outcomes. Similarly, sperm motility, semen parameters, sperm morphology, and sperm DNA fragmentation are crucial aspects of infertility diagnosis and semen analysis parameters in male fertility assessment. In some cases, hormone replacement therapy, ovulation induction, and accurate ovulation timing are incorporated into tailored treatment pathways.
Despite advances, stringent regulations across several countries pose challenges for the establishment of new ART centers. For example, in China, regulations mandate minimum staffing, including certified reproductive endocrinology specialists, trained laboratory personnel, and urologists, alongside infrastructure standards such as minimum lab space and specialized equipment. While such measures improve clinical oversight and patient safety, they may discourage new market entrants.
Finally, as patients increasingly seek fertility preservation and genetic screening services, the role of genetic counselors is becoming more prominent in guiding families through risks of chromosomal abnormalities and the application of preimplantation genetic screening. Ongoing research into follicular development, in vitro maturation, and embryo quality assessment further supports innovation in ART. Ultimately, the global ART market outlook will continue to depend on balancing treatment efficacy, regulatory compliance, and the evolving needs of infertility patients.
Europe is estimated to contribute 33% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Assisted Reproductive Technology (ART ) Market Demand is Rising in Europe Request Free Sample
The market in Europe is experiencing significant growth, driven by the increasing number of infertility cases among the region's aging population. Italy, the UK, Germany, France, and Spain were the major contributors to the European ART market in 2023. With fertility rates hovering around 1.5 children per woman in most European countries, advanced infertility treatments have become increasingly popular. These treatments, offered by hospitals and fertility clinics, are expected to provide substantial opportunities for end-users during the forecast period. Moreover, recent years have seen a surge in awareness initiatives by both government and non-government organizations, aimed at educating people about fertility complications and their associated treatments through various media channels.
This heightened awareness is leading to an increase in the demand for ART services, further fueling market growth. According to estimates, the operational efficiency gains from these advanced treatments can save up to 30% in costs and reduce compliance risks for patients and healthcare providers alike.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market is experiencing significant growth due to the increasing demand for solutions to address various infertility issues. One of the key factors driving market expansion is the impact of age on In Vitro Fertilization (IVF) success rates. Advanced technologies, such as improving embryo implantation through endometrial receptivity analysis, are being adopted to enhance fertility outcomes. Another significant area of focus is reducing multiple gestations, which is achieved through optimizing ovarian stimulation and minimizing the risk of ovarian hyperstimulation. Genetic screening for IVF is also gaining popularity, with preimplantation genetic diagnosis techniques, such as Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) and Preimplantation Genetic Testing for Aneuploidies (PGT-A), becoming increasingly common. Moreover, improving sperm quality is a critical aspect of ART , and advanced semen analysis techniques, as well as fertility preservation methods like cryopreservation, are being employed to address this challenge. Managing endometriosis and Polycystic Ovary Syndrome (PCOS) are also key concerns, with various treatments, such as minimally invasive surgery and advanced embryo culture systems, being utilized to improve oocyte selection methods and clinical pregnancy rates in IVF. Success rates by IVF procedure and live birth rates after IVF are significant metrics for evaluating the effectiveness of ART . Cost-effectiveness is another essential consideration, with time-lapse imaging analysis and improving semen analysis techniques contributing to more accurate diagnosis and treatment plans, ultimately leading to better outcomes and reduced healthcare costs. Overall, the ART market is continually evolving to address the diverse needs of patients and improve fertility outcomes.
The assisted reproductive technology (ART ) market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the assisted reproductive technology (ART ) market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Assisted Reproductive Technology (ART ) Industry
Companies are implementing various strategies, such as strategic alliances, assisted reproductive technology (ART ) market forecast, pART nerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Cook Group Inc. (United States) - This company specializes in providing advanced assisted reproductive technology services through innovative products, including the MNC Benchtop incubator. By leveraging cutting-edge technology, it ensures optimal conditions for fertilization and embryo development. The company's commitment to scientific excellence drives continuous improvement in reproductive healthcare solutions.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Assisted Reproductive Technology (ART ) Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.36% |
|
Market growth 2024-2028 |
USD 6295.3 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.11 |
|
Key countries |
US, UK, China, Germany, Japan, India, France, Netherlands, UAE, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What is the expected growth of the Assisted Reproductive Technology (ART ) Market between 2024 and 2028?
USD 6.3 billion, at a CAGR of 4.36%
What segmentation does the market report cover?
The report is segmented by End-User (Fertility clinics, Hospitals, Surgical centers, Research institutes/labs, and Cryobanks), Type (IVF, ART ificial insemination, GIFT (Gamete Intrafallopian Transfer), ZIFT (Zygote Intrafallopian Transfer), Surrogacy, and Donor egg/sperm ART ), Geography (Europe, North America, Asia, Middle East and Africa, South America, and Rest of World (ROW)), and Product (Instrument, Accessory and Disposable, Reagents and Media, and Software)
Which regions are analyzed in the report?
Europe, North America, Asia, and Rest of World (ROW)
What are the key growth drivers and market challenges?
Increase in rate of infertility and obesity-related cases, Side effects of infertility treatment
Who are the major players in the Assisted Reproductive Technology (ART ) Market?
Cook Group Inc. (United States), CRITEX GmbH (Germany), Cryolab Ltd. (United Kingdom), Esco Micro Pte. Ltd. (Singapore), Ferring BV (Netherlands), FUJIFILM Holdings Corp. (Japan), Genea Ltd. (Australia), Hamilton Thorne Ltd. (Canada), IMV Technologies (France), Instituto Bernabeu SL (Spain), INVO Bioscience Inc. (United States), KITAZATO Corp. (Japan), Merck KGaA (Germany), Monash IVF Group Ltd. (Australia), Pantec Engineering AG (Switzerland), Smiths Group Plc (United Kingdom), The Cooper Companies Inc. (United States), Virtus Health (Australia), Vitrolife AB (Sweden), and XiltriX International (Netherlands)
We can help! Our analysts can customize this assisted reproductive technology (ART ) market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Market Segmentation by End-User
9 Market Segmentation by Type
10 Market Segmentation by Geography
11 Market Segmentation by Product
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
